United Kingdom

People: Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

19 Jul 2019
Change (% chg)

$-0.29 (-0.67%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Read, Ian 

Mr. Ian C. Read is Executive Chairman of the Board of Pfizer Inc. He has been Chairman of the Board and Chief Executive Officer from December 2011 to December 2018. President and Chief Executive Officer from December 2010 until December 2011. Previously, he served as Senior Vice President and Group President of the Worldwide Biopharmaceutical Businesses, which he led from 2006 through December 2010. In that role, he oversaw five global business units—Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets. Chair of the Pfizer Foundation. Director of Kimberly-Clark Corporation.Mr. Read brings over 35 years of business, operating and leadership experience to the Board. His extensive knowledge of the biopharmaceutical industry in general, and Pfizer’s worldwide biopharmaceutical business in particular, provides crucial insight to our Board on the company’s strategic planning and operations. Mr. Read provides advice and counsel to management and the Board, and the combination of his knowledge of the business and his leadership skills makes his role as Executive Chairman optimal at this time. In addition, his experience as a member of another public company board provides him with an enhanced perspective on issues applicable to public companies.

Basic Compensation

Total Annual Compensation, USD 4,992,500
Restricted Stock Award, USD 7,030,630
Long-Term Incentive Plans, USD --
All Other, USD 7,526,080
Fiscal Year Total, USD 19,549,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 275,000 2,216,780.00
Name Fiscal Year Total

Ian Read


Albert Bourla


Frank D'Amelio


Mikael Dolsten


Michael Goettler


Angela Hwang

As Of  31 Dec 2018